Skip to content

Continuous TQL Block for Elective Cesarean Section

Ultrasound-guided Transmuscular Quadratus Lumborum Catheters for Elective Caesarean Section. A Double Blind, Randomise, Placebo Controlled Trial.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03663478
Enrollment
32
Registered
2018-09-10
Start date
2018-09-04
Completion date
2020-04-08
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local, Postoperative Pain

Brief summary

The aim of this study is to investigate whether it is possible to prolong time to first opioid with the TQL block by inserting catheters bilaterally, providing continuous analgesia, in patients undergoing elective CS. Our hypothesis is that it will be possible to significantly extend time to first opioid with the blockade by 66.6%, increasing it from a mean of 5.6 hours to a mean of 10 hours.

Interventions

DRUGRopivacaine

2 x 30 ml ropivacaine 0,2% and an elastomere pump with 200 ml ropivacaine 0,2%, infusion rate 8 ml/hour

DRUGSaline

2 x 30 mL isotonic saline and an elastomere pump with 200 ml isotonic saline, infusion rate 8 ml/hour

Sponsors

Zealand University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18+ years of age. * Scheduled for elective Caesarean Section in spinal anaesthesia. * Have received thorough information, verbally and in written, and signed the Informed Consent form on participation in the trial.

Exclusion criteria

* Inability to cooperate * Inability to understand Danish * Allergy to local anaesthetics or opioids * Excessive daily intake of opioids, according to the discretion of the investigator * Local infection at the site of injection or systemic infection * Difficult visualisation of muscular and fascial structures on ultrasound, necessary to correct blockade and catheter placement.

Design outcomes

Primary

MeasureTime frameDescription
Time to first opioid24 hours postoperativelyThe time from catheters placement to the administration of opioids

Secondary

MeasureTime frameDescription
Total morphine consumption.24 hoursMorphine consumption at 3, 6, 9, 12 and 24 postoperative hours (data from PCA pump and patient medical record).
Catheter displacement.24 hoursFrequency of displacement of catheters (early displacement evaluated after 2 hours (T2), late displacement evaluated after 24 hours (T24)).
Pain intensity (NRS 0-10/10)24 hours postoperativelyNRS (numeric rating scale) score in the study period at 3, 6, 9, 12 and 24 hours postoperatively. In addition, NRS score will be recorded electronically on all morphine administrations, since all patients must enter their NRS score on the Patient-Controlled Analgesia (PCA) pump display prior to administration of the PCA boluses. NRS is a pain scale where the patient gives her pain a number from 0-10, where 0 is no pain and 10 is the worst pain imaginable.
The degree of morphine-related side effects (PONV, itching, fatigue, etc.).24 hoursOn a scale from 0-3, where 0 is none, 1 is mild, 2 is moderate and 3 is severe.
Time from operation to ambulation.24 hoursTime from operation to ambulation.
Patient satisfaction with application of the catheters.24 hoursNRS 0-10/10 during placement of catheters

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026